Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Fennec Pharmaceuticals

NASDAQ FENC
$7.04 -0.08 -1.14%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 28 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

218.88M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
236.63M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-0.01
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
31.09M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-37.25 %

Upcoming events Fennec Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Fennec Pharmaceuticals

Stock analysis Fennec Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
80.69 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
-18.93 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
33.70 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
2.53 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
90.09 7.67

Price change Fennec Pharmaceuticals per year

5.80$ 9.83$
Min Max

Summary analysis Fennec Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Fennec Pharmaceuticals

Revenue and net income Fennec Pharmaceuticals

All parameters

Stock news Fennec Pharmaceuticals

All news
29 September 2022 в 15:51

Fennec Pharmaceuticals stock price target raised to $15 from $10 at Maxim Group

21 September 2022 в 18:21

Fennec Pharmaceuticals Shares Rally After FDA OK of Pedmark >FENC

21 September 2022 в 18:15

Fennec Pharmaceuticals Shares Rally After FDA OK of Pedmark >FENC

27 April 2022 в 13:36

Fennec Pharmaceuticals: FDA Accepts Pedmark Application's Resubmission

27 April 2022 в 13:36

Fennec Pharmaceuticals: FDA Accepts Pedmark Application's Resubmission

24 March 2022 в 13:21

Fennec Pharmaceuticals Files Again for FDA OK of Pedmark >FENC

24 March 2022 в 13:17

Fennec Pharmaceuticals Files Again for FDA OK of Pedmark >FENC

29 November 2021 в 14:31

Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again

29 November 2021 в 14:31

Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again

11 August 2020 в 16:08

Лидеры и аутсайдеры Уолл-cтрит: Safeguard Scientifics, Genesis Healthcare, Fennec Pharmaceuticals

About company Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Address:
68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Company name: Fennec Pharmaceuticals
Issuer ticker: FENC
ISIN: CA31447P1009
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2001-06-05
Sector: Healthcare
Industry: Biotechnology
Site: https://www.fennecpharma.com

On which stock exchange are Fennec Pharmaceuticals (FENC) stocks traded?

Fennec Pharmaceuticals (FENC) stocks are traded on NASDAQ.

What is the ticker of Fennec Pharmaceuticals stocks (FENC)?

The stock ticker of Fennec Pharmaceuticals’s stocks or in other words, the code is FENC. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Fennec Pharmaceuticals (FENC) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Fennec Pharmaceuticals (FENC) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Fennec Pharmaceuticals (FENC) stocks traded?

Fennec Pharmaceuticals (FENC) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Fennec Pharmaceuticals (FENC) stocks today?

The current price of Fennec Pharmaceuticals stocks on 19.05.2024 is 7.04 dollars. per share.

What is the dynamics of Fennec Pharmaceuticals (FENC) stocks from the beginning of the year?

Fennec Pharmaceuticals (FENC) quotes have increased by -36.69% from the beginning of the year up to 7.04 dollars. per 1 stocks.

How much did Fennec Pharmaceuticals (FENC) stocks increase in мае 2024?

This month Fennec Pharmaceuticals (FENC) quotes have increased by -22.55% to 7.04 dollars. per share.

How much are Fennec Pharmaceuticals (FENC) stocks worth?

Today, on October, 19.05.2024 Fennec Pharmaceuticals’s (FENC) stocks cost 7.04 dollars..

What is the market capitalization of Fennec Pharmaceuticals (FENC)?

Capitalization is the market value of Fennec Pharmaceuticals (FENC) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of Fennec Pharmaceuticals (FENC) is estimated at about 218880640 dollars.